Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
SHPH similar filings
- 31 Oct 24 Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
- 29 Oct 24 Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
- 28 Oct 24 Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
- 28 Oct 24 Shuttle Pharmaceuticals to Present at the 2024
- 25 Oct 24 Entry into a Material Definitive Agreement
- 17 Oct 24 Entry into a Material Definitive Agreement
- 13 Sep 24 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
Filing view
External links